Variant report
Variant | nsv980719 |
---|---|
Chromosome Location | chr5:120366364-120366995 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs151259931 | chr5:120366366-120366367 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs1422605 | chr5:120366397-120366398 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs546508768 | chr5:120366424-120366425 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571169942 | chr5:120366435-120366436 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140440005 | chr5:120366460-120366461 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs76505325 | chr5:120366494-120366495 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs150018051 | chr5:120366496-120366497 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536787741 | chr5:120366526-120366527 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs114130253 | chr5:120366555-120366556 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573490766 | chr5:120366577-120366578 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs537924963 | chr5:120366581-120366582 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534349441 | chr5:120366591-120366592 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs145234432 | chr5:120366608-120366609 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577656244 | chr5:120366687-120366688 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544566045 | chr5:120366690-120366691 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563328806 | chr5:120366702-120366703 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs77293394 | chr5:120366706-120366707 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs113135365 | chr5:120366710-120366711 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542731818 | chr5:120366711-120366712 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs77344590 | chr5:120366719-120366720 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs560617848 | chr5:120366763-120366764 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200705428 | chr5:120366794-120366795 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs528283318 | chr5:120366827-120366828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs75631419 | chr5:120366888-120366889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs193032356 | chr5:120366920-120366921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs577564316 | chr5:120366926-120366927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532477454 | chr5:120366929-120366930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs185367824 | chr5:120366977-120366978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs138765614 | chr5:120366987-120366988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:120361600-120368400 | Enhancers | Dnd41 | blood |
2 | chr5:120365200-120367000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr5:120365600-120367000 | Enhancers | NHDF-Ad | bronchial |
4 | chr5:120366000-120366800 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
5 | chr5:120366800-120367000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr5:120366800-120367200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
7 | chr5:120366800-120367600 | Enhancers | Fetal Heart | heart |
8 | chr5:120366800-120367600 | Enhancers | Fetal Muscle Leg | muscle |
9 | chr5:120366800-120367800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |